Literature DB >> 23086736

Assessing liver function using dynamic Gd-EOB-DTPA-enhanced MRI with a standard 5-phase imaging protocol.

Kazuhiro Saito1, Joseph Ledsam, Steven Sourbron, Jun Otaka, Yoichi Araki, Soichi Akata, Koichi Tokuuye.   

Abstract

PURPOSE: To evaluate liver function obtained by tracer-kinetic modeling of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) data acquired with a routine gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid (Gd-EOB-DTPA)-enhanced protocol.
MATERIALS AND METHODS: Data were acquired from 25 cases of nonchronic liver disease and 94 cases of cirrhosis. DCE-MRI was performed with a dose of 0.025 mmol/kg Gd-EOB-DTPA injected at 2 mL/sec. A 3D breath-hold sequence acquired 5 volumes of 72 slices each: precontrast, double arterial phase, portal phase, and 4-minute postcontrast. Regions of interest (ROIs) were selected semiautomatically in the aorta, portal vein, and whole liver on a middle slice. A constrained dual-inlet two-compartment uptake model was fitted to the ROI curves, producing three parameters: intracellular uptake rate (UR), extracellular volume (Ve), and arterial flow fraction (AFF).
RESULTS: Median UR dropped from 4.46 10(-2) min(-1) in the noncirrhosis to 3.20 in Child-Pugh A (P = 0.001), and again to 1.92 in Child-Pugh B (P < 0.0001). Median Ve dropped from 6.64 mL 100 mL(-1) in the noncirrhosis to 5.80 in Child-Pugh A (P = 0.01). Other combinations of Ve and AFF changes were not significant for any group.
CONCLUSION: UR obtained from tracer kinetic analysis of a routine DCE-MRI has the potential to become a novel index of liver function.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23086736     DOI: 10.1002/jmri.23907

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  23 in total

1.  Increase in left liver lobe function after preoperative right portal vein embolisation assessed with gadolinium-EOB-DTPA MRI.

Authors:  Dominik Geisel; Lutz Lüdemann; Thomas Keuchel; Maciej Malinowski; Daniel Seehofer; Martin Stockmann; Bernd Hamm; Bernhard Gebauer; Timm Denecke
Journal:  Eur Radiol       Date:  2013-05-08       Impact factor: 5.315

2.  A New Model for MR Evaluation of Liver Function with Gadoxetic Acid, Including Both Uptake and Excretion.

Authors:  Daniel Truhn; Christiane K Kuhl; Alexander Ciritsis; Alexandra Barabasch; Nils A Kraemer
Journal:  Eur Radiol       Date:  2018-06-15       Impact factor: 5.315

3.  Evaluation of Magnetic Resonance (MR) Biomarkers for Assessment of Response With Response Evaluation Criteria in Solid Tumors: Comparison of the Measurements of Neuroendocrine Tumor Liver Metastases (NETLM) With Various MR Sequences and at Multiple Phases of Contrast Administration.

Authors:  Gustavo Felipe Luersen; W Wei; Eric P Tamm; Priya R Bhosale; Janio Szklaruk
Journal:  J Comput Assist Tomogr       Date:  2016 Sep-Oct       Impact factor: 1.826

4.  Efficacy of liver parenchymal enhancement and liver volume to standard liver volume ratio on Gd-EOB-DTPA-enhanced MRI for estimation of liver function.

Authors:  Tomohide Yoneyama; Yoshihiko Fukukura; Kiyohisa Kamimura; Koji Takumi; Aya Umanodan; Shinichi Ueno; Masayuki Nakajo
Journal:  Eur Radiol       Date:  2013-12-20       Impact factor: 5.315

5.  Vascular input function correction of inflow enhancement for improved pharmacokinetic modeling of liver DCE-MRI.

Authors:  Jia Ning; Tilman Schubert; Kevin M Johnson; Alejandro Roldán-Alzate; Huijun Chen; Chun Yuan; Scott B Reeder
Journal:  Magn Reson Med       Date:  2017-11-10       Impact factor: 4.668

6.  Quantitative assessment of hepatic function: modified look-locker inversion recovery (MOLLI) sequence for T1 mapping on Gd-EOB-DTPA-enhanced liver MR imaging.

Authors:  Jeong Hee Yoon; Jeong Min Lee; Munyoung Paek; Joon Koo Han; Byung Ihn Choi
Journal:  Eur Radiol       Date:  2015-09-15       Impact factor: 5.315

7.  Dynamic contrast-enhanced MRI perfusion quantification in hepatocellular carcinoma: comparison of gadoxetate disodium and gadobenate dimeglumine.

Authors:  Daniel Stocker; Stefanie Hectors; Octavia Bane; Naik Vietti-Violi; Daniela Said; Paul Kennedy; Jordan Cuevas; Guilherme M Cunha; Claude B Sirlin; Kathryn J Fowler; Sara Lewis; Bachir Taouli
Journal:  Eur Radiol       Date:  2021-05-27       Impact factor: 5.315

8.  Age dependence of spleen- and muscle-corrected hepatic signal enhancement on hepatobiliary phase gadoxetate MRI.

Authors:  Simon Matoori; Johannes M Froehlich; Stefan Breitenstein; Aleksis Doert; Viktoria Pozdniakova; Dow-Mu Koh; Andreas Gutzeit
Journal:  Eur Radiol       Date:  2015-09-03       Impact factor: 5.315

9.  Gd-EOB-DTPA-enhanced MRI for monitoring future liver remnant function after portal vein embolization and extended hemihepatectomy: A prospective trial.

Authors:  Dominik Geisel; Philip Raabe; Lutz Lüdemann; Maciej Malinowski; Martin Stockmann; Daniel Seehofer; Johann Pratschke; Bernd Hamm; Timm Denecke
Journal:  Eur Radiol       Date:  2016-12-13       Impact factor: 5.315

10.  Gd-EOB-DTPA-enhanced MRI for the assessment of liver function and volume in liver cirrhosis.

Authors:  H Nilsson; L Blomqvist; L Douglas; A Nordell; I Janczewska; E Näslund; E Jonas
Journal:  Br J Radiol       Date:  2013-02-12       Impact factor: 3.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.